Andrew Nunn: TB Stream Stage 2 results

Andrew Nunn reviews the STREAM 2 clinical trial for TB treatment, starting with the emergence of MDR TB, and ending with the dilemma of whether an effective MDR treatment should be used to treat drug-sensitive disease.
Andrew is Senior Scientist and Professor of Epidemiology, based at the MRC Clinical Trials Unit at UCL. Web link: www.mrcctu.ucl...
Stream 2 weblink: www.mrcctu.ucl...
Stream 2 Lancet paper: www-sciencedir...
Stream 2 Lancet supplementary data: www.thelancet....
Stream 1 results weblink: www.mrcctu.ucl...